Search results with tag "Ccjm"
An algorithm for managing warfarin resistance - ccjm
www.ccjm.orgwarfarin (Coumadin) to get their international normal-ized ratio (INR) into the therapeutic range. The cause of warfarin resistance can be either acquired (eg, poor compliance, drug interactions, dietary interactions) or hereditary, but the genetic mechanisms of warfarin resistance are not well understood. This review offers an
Three neglected numbers in the CBC: The RDW, MPV ... - ccjm
www.ccjm.orging, an MPV higher than 10.1 fL was associat-ed with a risk of in-stent restenosis more than 3 times higher.8 The MPV has also been found to be higher in patients with type 2 diabetes than in con-trols, particularly in those with microvascular complications such as retinopathy or microal-buminuria.9 Conversely, in patients with cancer, a low
Can an ARB be given to patients who have had ... - ccjm
www.ccjm.orgK/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43(suppl 1):S1–S290. 16. Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for pa-tients with coronary and other atherosclerotic vascular
-ILEO-GCAECAL TUBERCULOSIS - ccjm
www.ccjm.org92,,-ILEO-GCAECAL TUBERCULOSIS CASE REPORT By A. E. MORTIMER WOOLF, M.B., F.R.C.S. Consulting Surgeon, Queen Mary's Hospitalfor the East End In March, I942, I was asked to see a managed 34 with pain in the region of the umbilicus,
ACC/AHA lipid guidelines: Personalized care to ... - ccjm
www.ccjm.orgsessment, newer nonstatin cholesterol-lowering drugs, special attention to patient subgroups, and consideration of the value of therapy, all with the aim of creating personalized treatment plans for each patient. Overall, the guidelines recommend shared decision-making to meet the individual needs of each patient. Cara Reiter-Brennan